Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2009 1
2010 2
2012 1
2013 1
2014 3
2015 3
2016 5
2017 4
2018 3
2019 3
2020 4
2021 8
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early-stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial.
van Heek L, Weindler J, Gorniak C, Kaul H, Müller H, Mettler J, Baues C, Fuchs M, Borchmann P, Ferdinandus J, Dietlein M, Voltin CA, Kobe C, Roth KS. van Heek L, et al. Among authors: muller h. Eur J Haematol. 2023 Dec;111(6):881-887. doi: 10.1111/ejh.14093. Epub 2023 Aug 29. Eur J Haematol. 2023. PMID: 37644732
Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP.
Jachimowicz RD, Klapper W, Glehr G, Müller H, Haverkamp H, Thorns C, Hansmann ML, Möller P, Stein H, Rehberg T, von Tresckow B, Reinhardt HC, Borchmann P, Chan FC, Spang R, Scott DW, Engert A, Steidl C, Altenbuchinger M, Rosenwald A. Jachimowicz RD, et al. Among authors: muller h. Leukemia. 2021 Dec;35(12):3589-3593. doi: 10.1038/s41375-021-01314-1. Epub 2021 Jun 10. Leukemia. 2021. PMID: 34112956 Free PMC article. No abstract available.
Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis.
Bröckelmann PJ, Müller H, Gillessen S, Yang X, Koeppel L, Pilz V, Marinello P, Kaskel P, Raut M, Fuchs M, Borchmann P, Engert A, von Tresckow B. Bröckelmann PJ, et al. Among authors: muller h. Leukemia. 2022 Mar;36(3):772-780. doi: 10.1038/s41375-021-01442-8. Epub 2021 Oct 9. Leukemia. 2022. PMID: 34628472 Free PMC article. Clinical Trial.
Turn-taking: From perception to speech preparation.
Wesselmeier H, Müller HM. Wesselmeier H, et al. Among authors: muller hm. Neurosci Lett. 2015 Nov 16;609:147-51. doi: 10.1016/j.neulet.2015.10.033. Epub 2015 Oct 23. Neurosci Lett. 2015. PMID: 26483323
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i).
Gillessen S, Hüttmann A, Vucinic V, Müller H, Plütschow A, Viardot A, Topp MS, Kobe C, Böll B, Eichenauer DA, Sasse S, Haverkamp H, Schmitz C, Borchmann S, Bröckelmann PJ, Heger JM, Fuchs M, Engert A, Borchmann P, von Tresckow B. Gillessen S, et al. Among authors: muller h. Br J Haematol. 2022 Feb;196(3):606-616. doi: 10.1111/bjh.17878. Epub 2021 Nov 14. Br J Haematol. 2022. PMID: 34775591 Clinical Trial.
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy.
Bröckelmann PJ, Müller H, Guhl T, Behringer K, Fuchs M, Moccia AA, Rank A, Soekler M, Vieler T, Pabst T, Baues C, von Tresckow B, Borchmann P, Engert A. Bröckelmann PJ, et al. Among authors: muller h. J Clin Oncol. 2021 Jan 10;39(2):107-115. doi: 10.1200/JCO.20.00947. Epub 2020 Oct 15. J Clin Oncol. 2021. PMID: 33058716
Metabolic Tumour Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma.
Mettler J, Müller H, Voltin CA, Baues C, Klaeser B, Moccia A, Borchmann P, Engert A, Kuhnert G, Drzezga AE, Dietlein M, Kobe C. Mettler J, et al. Among authors: muller h. J Nucl Med. 2018 Jun 7;60(2):207-11. doi: 10.2967/jnumed.118.210047. Online ahead of print. J Nucl Med. 2018. PMID: 29880508 Free PMC article.
41 results